-
Oct 20, 2015, 08:20 AM
by
Michael Croft
Bio-IT World | Several research groups have reported that the Hi-C technique, developed to study the 3D architecture of chromosomes, can be repurposed to assemble genomes de novo. Now, Dovetail Genomics has taken the next step with a service promising high-contiguity genomes with standard, short-read Illumina sequencers.
Full story
-
Oct 20, 2015, 08:19 AM
by
Michael Croft
PRINCETON, NJ - Oct 20, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Japans new Agency for Medical Research and Development (AMED) has selected Certaras Phoenix® WinNonlin® software for pharmacokinetic/pharmacodynamic (PK/PD) modeling and non-compartmental analysis of new drug candidates
Full story
-
Oct 19, 2015, 14:10 PM
by
Michael Croft
ST. LOUIS, MO, UNITED STATES - Oct 19, 2015 - Today, SyMyco, a joint venture between Symbiotic Sciences based in New Delhi, India and Mycorrhizal Applications (MA), based in Grants Pass, OR, announced it is expanding its U
Full story
-
Oct 16, 2015, 10:49 AM
by
Michael Croft
The New York Times | Dr. Heck shared the 2010 Nobel Prize in Chemistry for creating techniques to synthesize complex carbon molecules that are now used to make drugs, electronics and other products.
Full story
-
Oct 15, 2015, 10:45 AM
by
Michael Croft
Computerworld | Moving to the Cloud is changing more than just data location. It's changing everything about the skills IT workers need to do their jobs and what those jobs entail.
Full story
-
Oct 14, 2015, 16:45 PM
by
Michael Croft
Forbes | With a drug discovery business, an FDA-cleared test, and a new valuation at over $1 billions, 23andMe is once again on the upswing, writes Matthew Herper.
Full story
-
Oct 14, 2015, 13:30 PM
by
Michael Croft
Bio-IT World | The annual meeting of the ASHG convened last week in Baltimore, in the midst of a new Precision Medicine Initiative that aims to collect one million patients' genomes and medical records into a national cohort. As NIH Director Francis Collins spoke about the possibilities and social responsibilities of that project, ASHG President Neil Risch reflected on past and ongoing misuses of genetics, and a panel of science journalists considered how scientists can best engage the public, build trust, and help non-professionals wrangle with the real-world implications of new discoveries.
Full story
-
Oct 14, 2015, 09:39 AM
by
Michael Croft
MIT Technology Review | An American woman claims she is the first to undergo gene therapy to reverse aging. Judge for yourself.
Full story
-
Oct 12, 2015, 09:35 AM
by
Michael Croft
PRINCETON, NJ - Oct 12, 2015 - An international consortium of 39 partner organizations will be funded by the European Commission to work on the integration of new concepts for regulatory chemical safety assessment
Full story
-
Oct 12, 2015, 05:07 AM
by
Michael Croft
BERLIN, GERMANY - Oct 12, 2015 - Dr. Anna Baran is Chief Medical Officer at KCR and in this strategic role she has developed a complex viewpoint on the challenges her position entails for a CROx
Full story
-
Oct 9, 2015, 14:25 PM
by
Michael Croft
Bio-IT World | Companies including Illumina, Complete Genomics, Pacific Biosciences, Invitae, QIAGEN, and DNAnexus gathered this week at the annual meeting of the American Society of Human Genetics in Baltimore to show off their latest products and services.
Full story
-
Oct 9, 2015, 10:04 AM
by
Michael Croft
Computerworld | Amazon launched a handful of new services all aimed at getting companies onto its cloud platform Wednesday, including a new ruggedized box for shipping data to the cloud provider.
Full story
-
Oct 9, 2015, 09:41 AM
by
Michael Croft
The Atlantic | The country's genetic biobank is still in its earliest stages, but the government hopes to one day have enough donors to totally overhaul its health-care system.
Full story
-
Oct 8, 2015, 12:00 PM
by
Michael Croft
Bio-IT World In a live webinar today, GENALICE launched the Population Calling analysis module to their GENALICE MAP Next-Generation Sequencing (NGS) Data Analysis Suite. In partnership with Mount Sinai Hospital, Amazon Web Services, and Intel, GENALICE processed the whole genomes of 800 patients from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), an Alzheimer’s disease cohort during the webinar.
Full story
-
Oct 7, 2015, 14:30 PM
by
Michael Croft
MIDDLETON, WI - Oct 7, 2015 - PFS Clinical, which offers turnkey administrative solutions that address the key pain points of establishing and running a clinical trial office, has been engaged by City of Hope to provide Coverage Analysis (CA) to ensure its clinical research trials remain compliant with complex Medicare billing regulations
Full story
-
Oct 7, 2015, 02:54 AM
by
Michael Croft
PORTLAND, OR, UNITED STATES - Oct 7, 2015 - Smart pills are ingestible medical devices consisting of elements such as sensors, cameras, patches and trackers that help in better diagnostics and monitoring
Full story
-
Oct 6, 2015, 10:00 AM
by
Michael Croft
MobiHealthNews | GlaxoSmithKline and Epidemico won a 2015 Bio-IT World Best Practices award last year for ProjectCRAWL, an effort to survey social media to alert GSK to adverse events. Yesterday, GSK's director of pharmacovigilance gave an update on how the pharma is using Epidemico's data.
Full story
-
Oct 6, 2015, 03:32 AM
by
Michael Croft
HELSINKI, FINLAND - Oct 6, 2015 - BC Platforms, a world leader in genomic data management solutions, today announced that the University of Colorado Anschutz Medical Campus will use the companys world-leading, comprehensive data management program to support the launch of the universitys new personalized medicine initiative aiming at translating community genomics into individual well-being
Full story
-
Oct 5, 2015, 21:18 PM
by
Michael Croft
Computerworld | IBM will acquire object-based storage vendor Cleversafe in a move to bolster its cloud business unit with more flexibility and simplified management options in the hybrid cloud, it announced on Monday.
Full story
-
Oct 2, 2015, 10:19 AM
by
Michael Croft
MIT Technology Review | To truly change the world, Google's new holding company will need something that has eluded many previous industrial labs: an effective commercialization strategy.
Full story